Cargando…
COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445797/ https://www.ncbi.nlm.nih.gov/pubmed/34561140 http://dx.doi.org/10.1016/j.vaccine.2021.09.036 |
| _version_ | 1784568728943329280 |
|---|---|
| author | Mansuy, Jean Michel Sagna, Asséga Sylvain Laurent, Michael Izopet, Jacques |
| author_facet | Mansuy, Jean Michel Sagna, Asséga Sylvain Laurent, Michael Izopet, Jacques |
| author_sort | Mansuy, Jean Michel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8445797 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84457972021-09-17 COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination? Mansuy, Jean Michel Sagna, Asséga Sylvain Laurent, Michael Izopet, Jacques Vaccine Letter to the Editor Elsevier Ltd. 2021-10-15 2021-09-17 /pmc/articles/PMC8445797/ /pubmed/34561140 http://dx.doi.org/10.1016/j.vaccine.2021.09.036 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Mansuy, Jean Michel Sagna, Asséga Sylvain Laurent, Michael Izopet, Jacques COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination? |
| title | COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination? |
| title_full | COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination? |
| title_fullStr | COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination? |
| title_full_unstemmed | COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination? |
| title_short | COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination? |
| title_sort | covid-19 diagnosis in a senegalese company: a model for covid-19 vaccination? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445797/ https://www.ncbi.nlm.nih.gov/pubmed/34561140 http://dx.doi.org/10.1016/j.vaccine.2021.09.036 |
| work_keys_str_mv | AT mansuyjeanmichel covid19diagnosisinasenegalesecompanyamodelforcovid19vaccination AT sagnaassegasylvain covid19diagnosisinasenegalesecompanyamodelforcovid19vaccination AT laurentmichael covid19diagnosisinasenegalesecompanyamodelforcovid19vaccination AT izopetjacques covid19diagnosisinasenegalesecompanyamodelforcovid19vaccination |